(ISSN 2577-5820)
OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
The journal publishes all types of articles in English. There is no restriction on the length of the papers. We encourage authors to be concise but present their results in as much detail as necessary, as reviewers are expected to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2024): Submission to First Decision: 6.7 weeks; Submission to Acceptance: 14.4 weeks; Acceptance to Publication: 4 days (1-2 days of FREE language polishing included)
Special Issue
Pediatric Liver Transplantation
Submission Deadline: October 15, 2020 (Closed)
Guest Editor
Yasuhiko Sugawara, MD, PhD
Associate Professor, Pediatric Surgery and Transplantation Division, Department of Surgery, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-5783, Japan
Research Interests: Hepatobiliary surgery; liver transplantation; pediatric surgery and transplantation
About This Topic
Liver transplantation for pediatrics has now become one of the established operations. The 1 year survival rates are around 95% in elective cases and 80% for urgent cases indicated for acute liver failure. The favorable outcome may be partly due to improvements in medical and surgical preoperative and postoperative managements. Use of split-liver and living donors grafts has provided more organs for the patients. Newer immunosuppression regimens, for example, an induction therapy, have had an impact on surgical outcome. The success in the field produces a cohort of the children who underwent transplantation around the age of 1 year and are well alive for a long term after the operation. There still remains a long term problem on the complications of immunosuppressive drugs and non-compliance.
In this special issue, submissions related to the pediatric liver transplantation will be invited. Original research, quality and quantitative systematic analysis, review article, case reports pertaining on the pediatric liver transplantation are welcome for submission.
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (transplantation@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
Publication
Malignancies and Pediatric Liver Transplantation: Promising Management with the mTOR-inhibitor EverolimusAbstract Some malignancies such as hepatoblastoma may be an indication for liver transplantation (LT) or some, for example, post-transplant lymphoproliferative disease (PTLD) may develop after successful LT. An immunosuppressive therapy after LT can promote the recurrence of the primary malignancy. The mammalian target-of-rapamycin inhibitors (mTORi [...] |
Liver Transplantation as a Cure for Neurologically Advanced Wilson’s disease. Learning More from ExperienceAbstract Clinical presentation and progression of Wilson’s disease can be diverse in different groups of patients. While young children most likely to present with acute or chronic liver failure, older children and adults may exhibit extrahepatic manifestation like neuropsychiatric, cardiac, renal, pancreatic and several others. Diagnosis of Wilson [...] |
| 2023 |  |
|
| CiteScore | SJR | SNIP |
| 0.6 | 0.179 | 0.17 |
TOP
